K-Trip Forte Tablet contains Trypsin Chymotrypsin (100000 AU), a proteolytic enzyme formulation widely used for its anti-inflammatory, anti-edematous, and fibrinolytic properties. This medication is indicated for the management of acute and chronic inflammatory conditions, including postoperative swelling, trauma, and soft tissue injuries. Trypsin and chymotrypsin act by breaking down proteinaceous debris and inflammatory mediators at the site of injury, thereby facilitating faster resolution of inflammation and reduction of edema. Additionally, the enzymatic action promotes enhanced absorption of anti-inflammatory agents and accelerates wound healing. K-Trip Forte is commonly prescribed as an adjunct therapy in conditions such as arthritis, sports injuries, and post-surgical recovery to improve patient comfort and functional recovery. The recommended dosage and duration of therapy should be determined by a healthcare professional based on the severity of the condition and patient response. Contraindications include hypersensitivity to proteolytic enzymes and active bleeding disorders. Caution is advised in patients with bleeding tendencies or those on anticoagulant therapy. Adverse effects are rare but may include gastrointestinal discomfort or allergic reactions. K-Trip Forte Tablet should be stored in a cool, dry place, away from direct sunlight, and out of reach of children.